Medications Commonly Misused as Drugs: Risks and Prevention
Share
Misused medications: benzodiazepines, opioids, stimulants… what risks and what screening?
Some medications prescribed in a medical context can be misused for their psychoactive effects: sedation, euphoria, disinhibition, stimulation, or seeking a “high.” This misuse exposes to major risks: dependence, respiratory problems, loss of consciousness, accidents, interactions with alcohol, and overdose.
Important: this article aims to prevent and inform. It does not replace a doctor’s advice, a pharmacist or emergency service. Treatment should never be stopped abruptly without medical advice. In case of discomfort, loss of consciousness, suspected overdose, or accidental ingestion: call immediately 15, the 18 or the 112.
Understanding drug misuse
What is drug misuse?
Misuse refers to when a medication is used outside its medical indication, without a prescription, at an inappropriate dose, in a context of polyconsumption, or to achieve a psychoactive effect. The risk is particularly high with drugs acting on the central nervous system.
Why is the risk underestimated?
Because a medication can give a false sense of security. Yet, a prescription drug can become dangerous when combined with alcohol, narcotics, or other sedative medications or when taken without medical supervision.
Dependence
Some molecules cause physical and psychological dependence, with difficult withdrawal, anxiety, insomnia, pain, agitation, or neurological symptoms.
Accidents
Drowsiness, slowed reflexes, disorientation, and memory problems increase risks while driving, at work or during a responsibility-related activity.
Overdose
Opioids, benzodiazepines, hypnotics, and gabapentinoids can cause respiratory depression, especially when mixed with each other or with alcohol.
1. Benzodiazepines and related hypnotics
Benzodiazepines are prescribed notably for anxiety, insomnia, certain forms of epilepsy, or muscle spasms. They are also frequently mentioned in cases of misuse due to their sedative, anxiolytic, and amnesic effects.
Examples of relevant medications
- Alprazolam: Xanax®
- Bromazepam: Lexomil®
- Diazepam: Valium®
- Clonazepam: Rivotril®
- Zopiclone: Imovane®
- Zolpidem: Stilnox®
Effects sought during misuse
- Intense relaxation, disinhibition, or sensation of letting go
- Sedation, forced sleep, or hypnotic effect
- Loss of anxiety, paradoxical euphoria in some users
- Partial or total amnesia, particularly problematic in festive contexts
Main risks
- Physical and psychological dependence
- Memory disorders, confusion, disorientation
- Falls, accidents, risky behaviors
- Effects strongly worsened by alcohol and other central nervous system depressants
- Possible respiratory depression in case of overdose or mixing with opioids, alcohol, or pregabalin
Screening possible
Screening tests can detect the BZO family for benzodiazepines depending on the model used. However, related hypnotics like zolpidem or zopiclone should not be considered automatically detected by all standard tests. Choosing the panel is therefore essential.
2. Opiates, opioids, and substitution treatments
Opioids are used to manage moderate to severe pain or as part of substitution treatments. Their misuse is particularly dangerous as they can cause respiratory depression and overdose.
Examples of relevant medications
- Morphine: Skenan®, Moscontin®
- Codeine: codeine medications, prescription only
- Tramadol: Topalgic®, Contramal® and generics
- Oxycodone: strong opioid painkillers
- Fentanyl: Durogesic®, Actiq® and other controlled medical forms
- Buprenorphine: Subutex® and generics
- Methadone: opioid substitution treatment
Effects sought during misuse
- Euphoria, calming, sensation of warmth or well-being
- Reduction of physical or psychological pain
- Drowsiness, slowing down, “high” effect
- Seeking effects similar to illicit opiates
Main risks
- Overdose, coma, and respiratory arrest
- Rapid dependence and difficult withdrawal syndrome
- Major risk when combined with alcohol, benzodiazepines, pregabalin, or other sedatives
- Domestic, road, or work accidents related to drowsiness
- Extreme danger with powerful or synthetic opioids
Screening possible
Urine and saliva tests can detect certain opioids depending on the chosen reference: MOP/OPI for opiates like morphine or codeine, MTD for methadone, BUP for buprenorphine. Warning: tramadol, fentanyl or oxycodone may require specific panels and should not be equated with a automatic detection by a simple standard opiate test.
Regulatory note: French authorities have strengthened the regulation of tramadol, codeine and dihydrocodeine due to risks of misuse, dependence, abuse, and overdose. These developments show that medication diversion is not a marginal issue but a real public health challenge.
3. Stimulants and alertness medications
Some medications prescribed for ADHD, narcolepsy, or alertness are diverted to artificially improve concentration, reduce fatigue, or seek stimulation. The risk increases with repeated use, high doses or combined with other substances.
Examples of relevant medications
- Methylphenidate: Ritalin®, Concerta®, Medikinet®
- Modafinil: Modiodal®
- Dextroamphetamine / amphetamine salts: products not commonly marketed in France depending on specialties
- Pseudoephedrine: decongestant medications strictly regulated due to risks of side effects and diversion
Effects sought during misuse
- Increased energy and alertness
- Feeling of improved concentration
- Artificial reduction of fatigue
- Seeking academic, professional, or party performance
Main risks
- Tachycardia, hypertension, cardiovascular disorders
- Anxiety, agitation, irritability, insomnia
- Paranoia, hallucinations, or psychiatric disorders in vulnerable individuals
- Exhaustion, “crash,” mood drop after the stimulant effect
- Psychological dependence and normalization of use
Screening possible
The AMP, MET, or MDMA panels target amphetamines, methamphetamines or ecstasy according to tests. However, methylphenidate and modafinil should not be presented as automatically detected by amphetamine panels standards. A specific protocol or analysis may be necessary.
4. Pregabalin, gabapentin, and diverted antidepressants
Pregabalin and gabapentin are prescribed for certain neurological disorders or neuropathic pain. Pregabalin is subject to special monitoring in France due to an increase in misuse cases, of abuse, dependence, and forged prescriptions.
Examples of relevant medications
- Pregabalin: Lyrica® and generics
- Gabapentin: Neurontin® and generics
- Amitriptyline: Laroxyl®
- Other tricyclic antidepressants according to prescriptions
Effects sought during misuse
- Relaxation, calming, anxiety reduction
- Drowsiness or sedation
- Euphoric effects reported during non-medical use
- Dangerous enhancement of the effects of other substances
Main risks
- Consciousness disorders, confusion, disorientation
- Coma or respiratory depression in case of overdose or combination with opioids and sedatives
- Dependence and withdrawal syndrome
- Increased risk in polyconsumption situations
Screening possible
Tricyclic antidepressants can be detected with a TCA panel depending on the test used. However, pregabalin and gabapentin are not among the substances Detected by all standard rapid tests. A device or analysis adapted to the substance sought must be chosen.
5. Antihistamines, anticholinergics, and other diverted substances
Some non-opioid and non-benzodiazepine medications can also be diverted. The danger often comes Sedation, confusion, neurological disorders, and association with alcohol or other psychoactive products.
Examples of concerned substances
- Promethazine: Phenergan® and related specialties
- Doxylamine: antihistamine sleeping aids
- Hydroxyzine: anxiolytic antihistamine as prescribed
- Scopolamine / hyoscine: anticholinergic substance to be handled with caution in prevention content
- Barbiturates: rarer but still sought in certain toxicological contexts
Effects sought during misuse
- Sedation, drowsiness, or hypnotic effect
- Altered perceptions
- Confusion, disorientation, or memory loss
- Enhancement of the effects of other substances
Main risks
- Loss of consciousness, falls, fainting
- Significant confusion and dangerous behaviors
- Respiratory risk when combined with alcohol, opioids, or benzodiazepines
- Possible cardiac or neurological disorders depending on the molecule and context
Screening possible
Some urine tests may include panels such as BAR for barbiturates. For antihistamines, anticholinergics, zolpidem, zopiclone, or more specific substances, A targeted toxicological analysis may be necessary. Screening should always be chosen based on the substance sought.
Diverted medications and chemical submission
Drug diversion is not limited to recreational use. Sedative medications, Anxiolytics, hypnotics, antihistamines, antidepressants, or opioids can be involved in situations of chemical submission or chemical vulnerability. In these situations, a person can be made more vulnerable to assault, theft, or violence.
Key message: the victim is never responsible. Prevention must not place the burden of safety on victims. Tests, bracelets, glass condoms, awareness campaigns and screening protocols are complementary tools in a global prevention, support and fight against criminal behaviors.
Possible warning signs
- Blackout or unexplained memory loss
- Sudden drowsiness or feeling “disconnected”
- Loss of control, confusion, or disorientation
- Symptoms disproportionate to declared consumption
Useful reflexes
- Get to safety and inform a trusted person
- Contact emergency services in case of malaise or serious doubt
- Consult quickly to allow appropriate care
- Keep, if possible, useful items: glass, bottle, clothing, messages, testimonies
Collective prevention
- Train teams in festive and professional environments
- Set up listening points and alert procedures
- Equip events with prevention tools
- Plan clear referral to emergency services and specialized structures
Screening for diverted medications: saliva, urine, and limits to know
Screening can help identify certain substance families, but it must be used rigorously. A rapid test is a screening tool: depending on the context, a positive or doubtful result may require a laboratory confirmation, especially for medical, legal, disciplinary, or professional decisions.
Saliva test: recent use and field approach
Saliva tests are particularly suited to contexts where recent consumption is being investigated: road safety, workplace safety, awareness campaigns, supervised internal control or self-monitoring. Depending on the model, it can detect notably THC, cocaine, amphetamines, methamphetamines, opiates, MDMA or benzodiazepines.
Urine test: wider detection window
Urine tests are often preferred when multiple substance families need to be detected with a detection window generally broader detection. Depending on the chosen reference, it can detect THC, cocaine, amphetamines, methamphetamines, opiates, MDMA, benzodiazepines, methadone, buprenorphine, barbiturates, tricyclic antidepressants or certain new psychoactive substances.
Substances and families that can be detected according to the tests
Important limitation: no rapid test detects “all medications” or “all drugs.” Each device works with a specific panel. Before choosing a test, it is necessary to identify the family or families sought: benzodiazepines, opiates, methadone, buprenorphine, amphetamines, TCA, barbiturates, THC, cocaine, MDMA, etc.
How to choose the right screening test?
The choice of test depends on the context: personal use, workplace prevention, festive event, internal control, medical-social support or need for guidance after suspected exposure to a substance.
For recent use
The saliva test is generally preferred when recent use needs to be detected, notably in the context of road safety, workplace safety, or self-monitoring.
For broader screening
The urine test often covers more substance families, with a detection window generally longer detection depending on the substance, frequency of use, and metabolism.
For a company or organization
In the professional environment, screening must be regulated: internal rules, risk positions, compliance with confidentiality, employee information, and adapted protocol. AMA Prévention can guide companies towards solutions consistent with their needs.
Misused medications, driving, and workplace safety
Some medications can impair alertness, reflexes, coordination, memory, and danger perception. The risk is even higher when combined with alcohol, cannabis, cocaine, opioids, to benzodiazepines or other psychoactive substances.
Behind the wheel
- Drowsiness and decreased alertness
- Slowed reaction time
- Disinhibited or dangerous driving
- Increased risk of serious accident
- Saliva testing possible by law enforcement for certain drugs
At work
- Increased risk in safety-critical positions
- Handling machinery, operating vehicles, or sensitive interventions
- Impairment of judgment and coordination
- Employer's prevention responsibility
- Need for a clear, proportionate, and compliant protocol
Key point: a legally prescribed medication can still become incompatible with driving, certain professional tasks or alcohol consumption. In case of doubt, advice should be sought from a doctor Or a pharmacist and carefully read the driving pictograms on medication boxes.
Gendarmerie saliva test, THC and detection time: what you need to understand
During a roadside check, law enforcement can use a drug saliva test To detect certain drugs, notably cannabis, cocaine, amphetamines, methamphetamines, Opiates or ecstasy depending on the devices used.
How long can a THC saliva test remain positive?
The detection time of THC in saliva varies according to several factors: frequency of use, Amount consumed, time since last use, metabolism, oral hygiene, and test sensitivity. It can range from a few hours to longer in some regular users.
Can you buy an equivalent saliva test?
Individuals, businesses, and professionals can use saliva screening tests to Self-monitoring or prevention. AMA Prévention offers professional Drugdiag® tests, adapted to needs Rapid screening, with different panels depending on the substances tested.
Caution: a negative self-test never authorizes driving. The only valid driving Completely safe and compliant means no consumption of substances that could impair alertness.
Need a reliable test for prevention or self-monitoring?
AMA Prévention supports individuals, businesses, communities, pharmacies, healthcare professionals and event organizers with reliable, CE-certified screening solutions adapted for field use.
Frequently asked questions about diverted medications and screening
Does a saliva test detect benzodiazepines?
Yes, some saliva tests can include a BZO panel for benzodiazepines. However, you need to check the exact reference of the test, as not all devices test for the same families.
Does a urine test detect tramadol?
Not automatically. Tramadol may require a specific panel. A standard opiate test can detect Some molecules like morphine or codeine, but you should not assume it detects all opioids.
Is pregabalin detected by standard rapid tests?
Not in most standard panels. Pregabalin usually requires a specific test or analysis. It is therefore essential to choose the device according to the substance actually being tested for.
Should a positive test be confirmed in a laboratory?
In a medical, legal, professional, or disciplinary context, a rapid test should be considered as a guidance tool. Laboratory confirmation may be necessary depending on the protocol, the situation and the consequences of the decision.
Which tests to choose for a company?
For a company, the choice depends on the positions concerned, the substances to be detected, the internal regulations, the legal framework and prevention protocol. AMA Prévention can guide towards saliva or urine tests adapted to professional needs.
Conclusion
Medication misuse is a major public health issue. Benzodiazepines, opioids, stimulants, pregabalin, antihistamines, or antidepressants can present significant risks when used outside medical settings, mixed with alcohol or combined with other substances.
Prevention is based on three pillars: clear information, risk reduction and appropriate screening. Rapid tests can be useful, provided their panels are well understood, their limits and the possible need for laboratory confirmation.
Safety reminder
In case of loss of consciousness, malaise, suspected overdose, chemical submission, or accidental ingestion, immediately contact emergency services: 15, 18 or 112. Never leave an unconscious person alone.
Useful sources and reference organizations
- Drogues Info Service — information, listening, and guidance on drugs and addictions.
- ANSM — official information on medications, misuse risks, and pharmacovigilance.
- Health Insurance — health information, medications, prevention, and care pathways.
- Road safety — information on driving, alcohol, narcotics, and penalties.
Scientific validation of B-SAFE
The B-SAFE project, a drug detector pen for beverages, is validated and supported by Professor Jean-Claude Alvarez, toxicologist, professor of pharmacology-toxicology, and director of the toxicology laboratory at CHU Raymond-Poincaré/AP-HP in Garches.
As an authority in toxicology, he is associated with the reference work conducted in France on psychoactive substances and chemical submission, in a national ecosystem also supported in public debate by voices such as Sandrine Josso and Caroline Darian.
This validation strengthens B-SAFE's technological positioning and the accuracy of its detection for drug prevention in beverages. Discover the B-SAFE product sheet.
